Background: What is the impact of the exponential increase in the car fleet in cities?Aim: To describe the epidemiological, clinical, therapeutic and prognostic features of ocular trauma in Kara. Materials and methods:We conducted a retrospective and descriptive study from January 1 st , 2017, to December 31 st , 2020, a period of 4 years. Mechanical traumas were classified according to the Birmingham Eye Trauma Terminology (BETT), and prognosis was assessed according to the Ocular Trauma Score (OTS).Results: During the study period, 418 cases of ocular trauma were recorded, out of a total of 14652 consultations, corresponding to a frequency of 2.8%. The mean age was 28.5 ± 15.6 [1.92] years with a sex ratio of 2.22 (288M/130 F). In 5.5% of cases, patients consulted within 6 hours of trauma, and in 66.7% of cases, the delay of consultation time was more than 72 hours. The injury was bilateral in 11.5% of cases. Mechanical trauma accounted for 379 cases (90.7%), chemical burns 20 cases (4.8%) and thermal burns 19 cases (4.5%). Of the 379 cases of mechanical trauma, 342 cases (90.2%) were closed globe trauma, and 37 cases (9.8%) were open globe trauma. The circumstances of injury were domestic accidents with 115 cases (27.5%) followed by road accidents with 115 cases (25.1%), work accidents and brawls in equal proportion with 65 cases (15.6%), According to the OTS score, 345 cases (82.5%) had a score of 5, there were 35 cases (8.4%) with a score of 4, the score of 3 were found in 3 patients(6.2%) and the score of 2 and 1 were found in 6 patients each (1.4%). Treatment was surgical in 8.9% of cases and medical in 91.1% of cases. Conclusion:Ocular trauma is relatively common, better awareness will reduce consultation delays and improve prognosis. The best treatment remains prevention.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.